Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-07 1:06 pm Purchase | 13G | ESPERION THERAPEUTICS INC ESPR | BlackRock Inc. BLK | 5,509,187 7.5% | 3,267,970 (+145.81%) | View |
| 2023-01-20 4:13 pm Purchase | 13G | ESPERION THERAPEUTICS INC ESPR | MILLENNIUM MANAGEMENT LLC | 3,623,902 4.9% | 3,623,902 (New Position) | View |
| 2023-01-04 2:30 pm Unchanged | 13G | ESPERION THERAPEUTICS INC ESPR | Meditor Group Ltd | 4,468,835 6.1% | 0 (Unchanged) | View |
| 2022-08-23 4:59 pm Purchase | 13G | ESPERION THERAPEUTICS INC ESPR | Point72 Asset Management L.P. | 3,470,278 5.2% | 3,470,278 (New Position) | View |
| 2022-05-17 3:06 pm Sale | 13G | ESPERION THERAPEUTICS INC ESPR | Flynn James E | 5,000,000 4.99% | -5,000,000 (-50.00%) | View |
| 2022-02-14 3:19 pm Purchase | 13G | ESPERION THERAPEUTICS INC ESPR | CVI Investments Inc. | 6,722,709 9.9% | 448,324 (+7.15%) | View |
| 2022-02-11 4:39 pm Unchanged | 13G | ESPERION THERAPEUTICS INC ESPR | BB BIOTECH AG | 4,477,964 7.1% | 0 (Unchanged) | View |
| 2022-02-11 4:09 pm Unchanged | 13G | ESPERION THERAPEUTICS INC ESPR | Flynn James E | 10,000,000 8.06% | 0 (Unchanged) | View |
| 2022-02-11 2:54 pm Purchase | 13G | ESPERION THERAPEUTICS INC ESPR | WASATCH ADVISORS LP | 9,339,046 14.4% | 5,341,036 (+133.59%) | View |
| 2022-02-10 08:11 am Purchase | 13G | ESPERION THERAPEUTICS INC ESPR | VANGUARD GROUP INC | 3,761,439 6.06% | 1,396,132 (+59.03%) | View |
| 2022-02-09 1:02 pm Sale | 13G | ESPERION THERAPEUTICS INC ESPR | STATE STREET CORP STT | 1,046,377 1.69% | -1,476,167 (-58.52%) | View |
| 2022-01-12 2:15 pm Purchase | 13G | ESPERION THERAPEUTICS INC ESPR | Meditor Group Ltd | 4,468,835 7.1% | 1,789,000 (+66.76%) | View |
| 2022-01-10 12:54 pm Purchase | 13G | ESPERION THERAPEUTICS INC ESPR | BlackRock Inc. BLK | 2,241,217 3.6% | 177,012 (+8.58%) | View |
| 2022-01-04 9:16 pm Sale | 13G | ESPERION THERAPEUTICS INC ESPR | SABBY MANAGEMENT LLC | 3,095,410 11% | -2,618,876 (-45.83%) | View |
| 2021-12-10 12:18 pm Purchase | 13G | ESPERION THERAPEUTICS INC ESPR | CVI Investments Inc. | 6,274,385 9.9% | 6,274,385 (New Position) | View |
| 2021-12-09 4:54 pm Purchase | 13G | ESPERION THERAPEUTICS INC ESPR | Deep Track Capital LP | 6,345,790 9.99% | 6,345,790 (New Position) | View |
| 2021-12-09 10:11 am Purchase | 13G | ESPERION THERAPEUTICS INC ESPR | SABBY MANAGEMENT LLC | 5,714,286 11% | 5,714,286 (New Position) | View |
| 2021-12-07 5:19 pm Purchase | 13G | ESPERION THERAPEUTICS INC ESPR | Flynn James E | 10,000,000 8.17% | 10,000,000 (New Position) | View |
| 2021-05-28 5:00 pm Unchanged | 13G | ESPERION THERAPEUTICS INC ESPR | BB BIOTECH AG | 4,477,964 15.9% | 0 (Unchanged) | View |
| 2021-02-16 4:42 pm Sale | 13G | ESPERION THERAPEUTICS INC ESPR | Pentwater Capital Management LP | 722,580 2.59% | -1,545,681 (-68.14%) | View |